The University of Queensland

The Neurokinin 3 Receptor is a New Target for the Treatment of Autism Spectrum Disorder (2023–2027)

Grant type:

NHMRC IDEAS Grants

Researchers:

• 

  Dr Nathalie Dehorter

  Senior Research Fellow
  

  Queensland Brain Institute

Funded by:

National Health and Medical Research Council